New Artery-Directed chemo shows promise for tough pancreatic tumors
NCT ID NCT07497204
First seen Apr 05, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study looked at 60 people with advanced pancreatic body or tail cancer that couldn't be removed by surgery. It compared standard chemotherapy given through a vein to a more targeted method where chemo is delivered directly to the spleen artery, aiming to get more drug to the tumor with fewer body-wide side effects. The goal was to see if this approach could help people live longer and have better control of their cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER (UNRESECTABLE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.